Comparative roles of microvascular and nerve function in foot ulceration in type 2 diabetes

被引:24
|
作者
Krishnan, STM
Baker, NR
Carrington, AL
Rayman, G
机构
[1] Ipswich Hosp NHS Trust, Ipswich Diabet Ctr, Ipswich, Suffolk, England
[2] Ipswich Hosp NHS Trust, Ipswich Diabet Food Unit, Ipswich, Suffolk, England
关键词
D O I
10.2337/diacare.27.6.1343
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To determine the relative roles of different modalities of sensory nerve function (large and small fiber) and the role of microvascular dysfunction in foot ulceration in type 2 diabetic subjects. RESEARCH DESIGN AND METHODS- A total of 20 control subjects and 18 type 2 diabetic subjects with foot ulceration and 20 without were studied. None of the subjects had clinical features of peripheral vascular disease. The Computer-Aided Sensory Evaluator IV (CASE IV) was used to determine vibration detection threshold (VDT), cold detection threshold (CDT), warm detection threshold (WDT), and heat pain onset threshold (HPO). Vibration perception threshold (VPT) was also assessed by a neurothesiometer. Microvascular function (maximum hyperemia to skin heating to 44 C) was assessed using laser Doppler flowmetry (mean maximum hyperemia using laser Doppler flowmeter [LDFmax]), laser Doppler imaging, and skin oxygenation with (mean maximum hyperemia using laser Doppler imager [LDFmax]) transcutaneous oxygen tension (TcpO(2)). RESULTS - VPT, VDT, CDT, and HPO were all signicantly higher in individuals with ulceration than in those without (VPT and VDT: P < 0.0001) (CDT and HPO: P = 0.01). LDFmax, LDImax, and TcpO(2) were significantly lower in the two diabetic groups than in the control subjects, but there was no difference between individuals with and without ulceration. Univariate logistic regression analysis revealed similar odds ratios for foot ulceration for VDT, CDT, HPO, and VPT (OR 1.97 [95% CI 1.30-2.98], 1.58 [1.20-2.08], 2.30 [1.21-4.37], and 1.24 [1.08-1.42], respectively). None of the microvascular parameters yielded significant odds ratios for ulceration. CONCLUSIONS - This study found that there was no additional value in measuring small-fiber function with the CASE IV over measuring vibration by either CASE IV or the inexpensive neurothesiometer in discriminating between individuals with and without ulceration. Furthermore, none of the tests of microvascular function including the TcpO(2) were able to discriminate between individuals with and without ulceration, suggesting that such tests may not be of benefit in identifying subjects at greater risk of foot ulceration.
引用
收藏
页码:1343 / 1348
页数:6
相关论文
共 50 条
  • [31] Comparison of the microvascular effects of glibenclamide and glimepiride in dorsal foot skin perfusion in type 2 diabetes
    Parson, Henri K.
    Colberg, Sheri R.
    Dublin, Charlotte B.
    Azoury, Krystel R.
    Vinik, Aaron I.
    DIABETES, 2006, 55 : A189 - A189
  • [32] Microvascular outcomes in type 2 diabetes
    Stehouwer, Coen D. A.
    van Sloten, Thomas T.
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (08): : 579 - 579
  • [33] Effects of pioglitzone and glimepiride on microvascular function in patients with diabetes mellitus type 2
    Forst, T
    Nguyen, M
    Langenfeld, M
    Friedrich, C
    Lübben, G
    Fennenkötter, U
    Kann, P
    Pfützner, A
    DIABETES, 2004, 53 : A308 - A308
  • [34] Assessment of sudomotor function as a screening tool for microvascular complications in type 2 diabetes
    Eranki, V.
    Calvet, J. -H.
    DIABETOLOGIA, 2013, 56 : S494 - S494
  • [35] Peak oxygen consumption and microvascular function in adults with Type 2 diabetes.
    Middlebrooke, AR
    Armstrong, N
    Shore, AC
    Welsman, JR
    MacLeod, KM
    DIABETOLOGIA, 2002, 45 : A285 - A285
  • [36] Dapagliflozin Improves Endothelial Function and Microvascular Reactivity in Type 2 Diabetes Mellitus
    Korzh, Oleksii
    Titkova, Anna
    Krasnokutskiy, Sergiy
    AMERICAN HEART JOURNAL, 2020, 229 : 168 - 168
  • [37] Sudomotor function assessment as a screening tool for microvascular complications in type 2 diabetes
    Eranki, V. G.
    Santosh, R.
    Rajitha, K.
    Pillai, A.
    Sowmya, P.
    Dupin, J.
    Calvet, J. H.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2013, 101 (03) : E11 - E13
  • [38] Rosuvastation improves objective signs of neuropathy and microvascular function in type 2 diabetes
    Parson, Henri K.
    Dublin, Charlotte B.
    Vinik, Aaron I.
    DIABETES, 2007, 56 : A210 - A210
  • [39] Osteoprotegerin Is Associated with Cardiovascular Autonomic Nerve Function in Type 2 Diabetes
    Maser, Raelene E.
    Lenhard, M. James
    DIABETES, 2014, 63 : A146 - A146
  • [40] Effects of Liraglutide on Somatic Nerve Function in Subjects with Type 2 Diabetes
    Casellini, Carolina M.
    Parson, Henri
    Bailey, Michael D.
    Siraj, Elias S.
    DIABETES, 2022, 71